Inhibition and Reversal of Microbial Attachment by an Antibody with Parasteric Activity against the FimH Adhesin of Uropathogenic E. coli

PLoS Pathogens

Volumn 11, Issue 5, 2015, Pages

  Kisiela, Dagmara I ^a   Avagyan, Hovhannes ^a   Friend, Della ^b   Jalan, Aachal ^a   Gupta, Shivani ^c   Interlandi, Gianluca ^c   Liu, Yan ^d   Tchesnokova, Veronika ^a   Rodriguez, Victoria B ^c   Sumida, John P ^a   Strong, Roland K ^b   Wu, Xue Ru ^d   Thomas, Wendy E ^c   Sokurenko, Evgeni V ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c University of Washington   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; FIMH ADHESIN; UNCLASSIFIED DRUG; FIMBRIA PROTEIN; FIMH PROTEIN, E COLI; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ADHERENCE; BIOFILM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; SURFACE PLASMON RESONANCE; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; C57BL MOUSE; FIMBRIA; IMMUNOLOGY; MALE; METABOLISM; MOLECULAR MODEL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; EUKARYOTA; MUS;

ADHESINS, ESCHERICHIA COLI; ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL ADHESION; FEMALE; FIMBRIAE PROTEINS; FIMBRIAE, BACTERIAL; MALE; MICE, INBRED C57BL; MODELS, MOLECULAR; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84930354056     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004857     Document Type: Article

References (66)

1. Swinney DC, (2004) Biochemical mechanisms of drug action: what does it take for success? Nat Rev Drug Discov 3: 801–808. 15340390
2. Christopoulos A, (2002) Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 1: 198–210. 12120504
3. Swinney DC, (2006) Biochemical mechanisms of New Molecular Entities (NMEs) approved by United States FDA during 2001–2004: mechanisms leading to optimal efficacy and safety. Curr Top Med Chem 6: 461–478. 16719803
4. Jones CH, Pinkner JS, Roth R, Heuser J, Nicholes AV, et al. (1995) FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci U S A 92: 2081–2085. 7892228
5. Chen SL, Hung CS, Pinkner JS, Walker JN, Cusumano CK, et al. (2009) Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc Natl Acad Sci U S A 106: 22439–22444. doi: 10.1073/pnas.0902179106 20018753
6. Connell I, Agace W, Klemm P, Schembri M, Marild S, et al. (1996) Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A 93: 9827–9832. 8790416
7. Krogfelt KA, Bergmans H, Klemm P, (1990) Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun 58: 1995–1998. 1971261
8. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ, (2000) Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. Embo J 19: 2803–2812. 10856226
9. Kisielius PV, Schwan WR, Amundsen SK, Duncan JL, Schaeffer AJ, (1989) In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections. Infect Immun 57: 1656–1662. 2566580
10. Choudhury D, Thompson A, Stojanoff V, Langermann S, Pinkner J, et al. (1999) X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. Science 285: 1061–1066. 10446051
11. Le Trong I, Aprikian P, Kidd BA, Forero-Shelton M, Tchesnokova V, et al. (2010) Structural basis for mechanical force regulation of the adhesin FimH via finger trap-like beta sheet twisting. Cell 141: 645–655. doi: 10.1016/j.cell.2010.03.038 20478255
12. Aprikian P, Tchesnokova V, Kidd B, Yakovenko O, Yarov-Yarovoy V, et al. (2007) Interdomain interaction in the FimH adhesin of Escherichia coli regulates the affinity to mannose. J Biol Chem 282: 23437–23446. 17567583
13. Tchesnokova V, Aprikian P, Yakovenko O, Larock C, Kidd B, et al. (2008) Integrin-like allosteric properties of the catch bond-forming FimH adhesin of Escherichia coli. J Biol Chem 283: 7823–7833. doi: 10.1074/jbc.M707804200 18174167
14. Chen W, Lou J, Evans EA, Zhu C, (2012) Observing force-regulated conformational changes and ligand dissociation from a single integrin on cells. J Cell Biol 199: 497–512. doi: 10.1083/jcb.201201091 23109670
15. Phan UT, Waldron TT, Springer TA, (2006) Remodeling of the lectin-EGF-like domain interface in P- and L-selectin increases adhesiveness and shear resistance under hydrodynamic force. Nat Immunol 7: 883–889. 16845394
16. Sooriyaarachchi S, Ubhayasekera W, Park C, Mowbray SL, (2010) Conformational changes and ligand recognition of Escherichia coli D-xylose binding protein revealed. J Mol Biol 402: 657–668. doi: 10.1016/j.jmb.2010.07.038 20678502
17. Avlani VA, Gregory KJ, Morton CJ, Parker MW, Sexton PM, et al. (2007) Critical role for the second extracellular loop in the binding of both orthosteric and allosteric G protein-coupled receptor ligands. J Biol Chem 282: 25677–25686. 17591774
18. Kim YJ, Hofmann KP, Ernst OP, Scheerer P, Choe HW, et al. (2013) Crystal structure of pre-activated arrestin p44. Nature 497: 142–146. doi: 10.1038/nature12133 23604253
19. Ma Q, Akhter Y, Wilmanns M, Ehebauer MT, (2014) Active site conformational changes upon reaction intermediate biotinyl-5'-AMP binding in biotin protein ligase from Mycobacterium tuberculosis. Protein Sci 23: 932–939. doi: 10.1002/pro.2475 24723382
20. Melcher K, Ng LM, Zhou XE, Soon FF, Xu Y, et al. (2009) A gate-latch-lock mechanism for hormone signalling by abscisic acid receptors. Nature 462: 602–608. doi: 10.1038/nature08613 19898420
21. Wagner DA, Czajkowski C, (2001) Structure and dynamics of the GABA binding pocket: A narrowing cleft that constricts during activation. J Neurosci 21: 67–74. 11150321
22. Carlson KE, Choi I, Gee A, Katzenellenbogen BS, Katzenellenbogen JA, (1997) Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction. Biochemistry 36: 14897–14905. 9398213
23. Lebon G, Warne T, Edwards PC, Bennett K, Langmead CJ, et al. (2011) Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature 474: 521–525. doi: 10.1038/nature10136 21593763
24. Duan X, Hall JA, Nikaido H, Quiocho FA, (2001) Crystal structures of the maltodextrin/maltose-binding protein complexed with reduced oligosaccharides: flexibility of tertiary structure and ligand binding. J Mol Biol 306: 1115–1126. 11237621
25. Quiocho FA, Spurlino JC, Rodseth LE, (1997) Extensive features of tight oligosaccharide binding revealed in high-resolution structures of the maltodextrin transport/chemosensory receptor. Structure 5: 997–1015. 9309217
26. Spurlino JC, Lu GY, Quiocho FA, (1991) The 2.3-A resolution structure of the maltose- or maltodextrin-binding protein, a primary receptor of bacterial active transport and chemotaxis. J Biol Chem 266: 5202–5219. 2002054
27. Rasmussen SG, Choi HJ, Fung JJ, Pardon E, Casarosa P, et al. (2011) Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor. Nature 469: 175–180. doi: 10.1038/nature09648 21228869
28. Csermely P, Palotai R, Nussinov R, (2010) Induced fit, conformational selection and independent dynamic segments: an extended view of binding events. Trends Biochem Sci 35: 539–546. doi: 10.1016/j.tibs.2010.04.009 20541943
29. Gianni S, Dogan J, Jemth P, (2014) Distinguishing induced fit from conformational selection. Biophys Chem 189: 33–39. doi: 10.1016/j.bpc.2014.03.003 24747333
30. Hatzakis NS, (2014) Single molecule insights on conformational selection and induced fit mechanism. Biophys Chem 186C: 46–54.
31. Silva DA, Bowman GR, Sosa-Peinado A, Huang X, (2011) A role for both conformational selection and induced fit in ligand binding by the LAO protein. PLoS Comput Biol 7: e1002054. doi: 10.1371/journal.pcbi.1002054 21637799
32. Dissing J, Rangaard B, Christensen U, (1993) Activity modulation of the fast and slow isozymes of human cytosolic low-molecular-weight acid phosphatase (ACP1) by purines. Biochim Biophys Acta 1162: 275–282. 8457591
33. Kisiela DI, Rodriguez VB, Tchesnokova V, Avagyan H, Aprikian P, et al. (2013) Conformational inactivation induces immunogenicity of the receptor-binding pocket of a bacterial adhesin. Proc Natl Acad Sci U S A 110: 19089–19094. doi: 10.1073/pnas.1314395110 24191044
34. Brochet X, Lefranc MP, Giudicelli V, (2008) IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36: W503–508. doi: 10.1093/nar/gkn316 18503082
35. Giudicelli V, Brochet X, Lefranc MP, (2011) IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb Protoc 2011: 695–715. doi: 10.1101/pdb.prot5633 21632778
36. Ehlert FJ, (1988) Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol Pharmacol 33: 187–194. 2828914
37. Kenakin T, (2004) Allosteric modulators: the new generation of receptor antagonist. Mol Interv 4: 222–229. 15304558
38. Hung CS, Bouckaert J, Hung D, Pinkner J, Widberg C, et al. (2002) Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol Microbiol 44: 903–915. 12010488
39. Nilsson LM, Thomas WE, Trintchina E, Vogel V, Sokurenko EV, (2006) Catch bond-mediated adhesion without a shear threshold: trimannose versus monomannose interactions with the FimH adhesin of Escherichia coli. J Biol Chem 281: 16656–16663. 16624825
40. Nilsson LM, Thomas WE, Sokurenko EV, Vogel V, (2008) Beyond induced-fit receptor-ligand interactions: structural changes that can significantly extend bond lifetimes. Structure 16: 1047–1058. doi: 10.1016/j.str.2008.03.012 18611378
41. Wu Y, Eigenbrot C, Liang WC, Stawicki S, Shia S, et al. (2007) Structural insight into distinct mechanisms of protease inhibition by antibodies. Proc Natl Acad Sci U S A 104: 19784–19789. 18077410
42. Mukund S, Shang Y, Clarke HJ, Madjidi A, Corn JE, et al. (2013) Inhibitory mechanism of an allosteric antibody targeting the glucagon receptor. J Biol Chem 288: 36168–36178. doi: 10.1074/jbc.M113.496984 24189067
43. Luo BH, Strokovich K, Walz T, Springer TA, Takagi J, (2004) Allosteric beta1 integrin antibodies that stabilize the low affinity state by preventing the swing-out of the hybrid domain. J Biol Chem 279: 27466–27471. 15123676
44. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, et al. (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322: 1211–1217. doi: 10.1126/science.1164772 18832607
45. Boehr DD, Nussinov R, Wright PE, (2009) The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol 5: 789–796. doi: 10.1038/nchembio.232 19841628
46. Seo MH, Park J, Kim E, Hohng S, Kim HS, (2014) Protein conformational dynamics dictate the binding affinity for a ligand. Nat Commun 5: 3724. doi: 10.1038/ncomms4724 24758940
47. Henzler-Wildman K, Kern D, (2007) Dynamic personalities of proteins. Nature 450: 964–972. 18075575
48. Goh CS, Milburn D, Gerstein M, (2004) Conformational changes associated with protein-protein interactions. Curr Opin Struct Biol 14: 104–109. 15102456
49. Wolf-Watz M, Thai V, Henzler-Wildman K, Hadjipavlou G, Eisenmesser EZ, et al. (2004) Linkage between dynamics and catalysis in a thermophilic-mesophilic enzyme pair. Nat Struct Mol Biol 11: 945–949. 15334070
50. Warne T, Moukhametzianov R, Baker JG, Nehme R, Edwards PC, et al. (2011) The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor. Nature 469: 241–244. doi: 10.1038/nature09746 21228877
51. Kim E, Lee S, Jeon A, Choi JM, Lee HS, et al. (2013) A single-molecule dissection of ligand binding to a protein with intrinsic dynamics. Nat Chem Biol 9: 313–318. doi: 10.1038/nchembio.1213 23502425
52. Tang C, Schwieters CD, Clore GM, (2007) Open-to-closed transition in apo maltose-binding protein observed by paramagnetic NMR. Nature 449: 1078–1082. 17960247
53. Hino T, Arakawa T, Iwanari H, Yurugi-Kobayashi T, Ikeda-Suno C, et al. (2012) G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody. Nature 482: 237–240. doi: 10.1038/nature10750 22286059
54. Doern A, Cao X, Sereno A, Reyes CL, Altshuler A, et al. (2009) Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo. J Biol Chem 284: 10254–10267. doi: 10.1074/jbc.M809709200 19211557
55. Nilsson LM, Thomas WE, Sokurenko EV, Vogel V, (2006) Elevated shear stress protects Escherichia coli cells adhering to surfaces via catch bonds from detachment by soluble inhibitors. Appl Environ Microbiol 72: 3005–3010. 16598008
56. Ding AM, Palmer RJ, Jr.Cisar JO, Kolenbrander PE, (2010) Shear-enhanced oral microbial adhesion. Appl Environ Microbiol 76: 1294–1297. doi: 10.1128/AEM.02083-09 20023085
57. Tchesnokova V, McVeigh AL, Kidd B, Yakovenko O, Thomas WE, et al. (2010) Shear-enhanced binding of intestinal colonization factor antigen I of enterotoxigenic Escherichia coli. Mol Microbiol 76: 489–502. doi: 10.1111/j.1365-2958.2010.07116.x 20345656
58. George NP, Wei Q, Shin PK, Konstantopoulos K, Ross JM, (2006) Staphylococcus aureus adhesion via Spa, ClfA, and SdrCDE to immobilized platelets demonstrates shear-dependent behavior. Arterioscler Thromb Vasc Biol 26: 2394–2400. 16857949
59. Misumi S, Endo M, Mukai R, Tachibana K, Umeda M, et al. (2003) A novel cyclic peptide immunization strategy for preventing HIV-1/AIDS infection and progression. J Biol Chem 278: 32335–32343. 12771150
60. Hoogerhout P, Donders EM, van Gaans-van den Brink JA, Kuipers B, Brugghe HF, et al. (1995) Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis. Infect Immun 63: 3473–3478. 7543883
61. Liu Y, El-Achkar TM, Wu XR, (2012) Tamm-Horsfall protein regulates circulating and renal cytokines by affecting glomerular filtration rate and acting as a urinary cytokine trap. J Biol Chem 287: 16365–16378. doi: 10.1074/jbc.M112.348243 22451664
62. Myszka DG, (1999) Improving biosensor analysis. J Mol Recognit 12: 279–284. 10556875
63. Brooks BR, Brooks CL, 3rdMackerell AD, Jr.Nilsson L, Petrella RJ, et al. (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30: 1545–1614. doi: 10.1002/jcc.21287 19444816
64. MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, et al. (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102: 3586–3616. doi: 10.1021/jp973084f 24889800
65. Bouckaert J, Berglund J, Schembri M, De Genst E, Cools L, et al. (2005) Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol 55: 441–455. 15659162
66. Wellens A, Garofalo C, Nguyen H, Van Gerven N, Slattegard R, et al. (2008) Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS One 3: e2040. doi: 10.1371/journal.pone.0002040 18446213